Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study is to help elucidate the effects of low-dose aspirin in combination with folic acid on the incidence of live births and spontaneous abortions among a group of women who become pregnant compared to a control group.


Clinical Trial Description

Despite the fundamental nature of reproduction, for many it is a process fraught with frustration, inefficiency and imperfections, the effects of which can be severe. Infertility affects 10-15% of couples attempting to conceive. Among all women who conceive, the incidence of spontaneous abortion (SA) has been estimated to be between 15 and 31%, and in many cases the cause is unknown. Additionally, of the four million births yearly in the United States, between 8 and 15% will be born prematurely and experience increased morbidity and mortality as a result. An intervention with even a small absolute effect on any of these outcomes has great implications at the population level due to the large potential attributable benefit.

One such potential intervention is low-dose acetylsalicylic-acid (aspirin). Aspirin has been a primary target of interest because of its anti-inflammatory, vasodilatory and platelet aggregation inhibition properties. To evaluate the effects of low-dose aspirin in combination with folic acid on the incidence of live births and spontaneous abortion, we are conducting a multi-site randomized controlled trial study with two sites and one data coordinating center. Women aged 18-40 currently trying to become pregnant and who have had a single spontaneous abortion in the past year will be eligible for the study. The recruitment goal is 1600 women. Participating women will be randomly assigned to one of two treatment groups. Those randomized to treatment will receive daily low-dose aspirin. Those randomized to placebo will receive daily placebo. Both groups will receive folic acid daily in accordance with recommendations from the U.S. Public Health Service for prevention of birth defects. The duration of treatment regimens (LDA and folic acid or placebo and folic acid) will be 6 menstrual cycles, with those who become pregnant continuing until the end of pregnancy. Monthly urine and blood samples will be collected and questionnaires administered. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00467363
Study type Interventional
Source Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contact
Status Completed
Phase N/A
Start date June 2007
Completion date July 2012

See also
  Status Clinical Trial Phase
Completed NCT02657200 - Knowledge, Attitude and Practices of Flemish Midwifes Regarding Spontaneous Abortion N/A
Recruiting NCT03332706 - the Association Between Blood's and Urinary Heavy Metal Level in Pregnant Women and the Spontaneous Abortion N/A
Recruiting NCT04003064 - Heavy Metals' Influence on Early Pregnancy Through Oxidative Stress
Completed NCT01857310 - Folic Acid and Zinc Supplementation Trial (FAZST) N/A
Recruiting NCT04456660 - Comprehensive Assessment of Risks for Miscarriage.
Completed NCT00878098 - Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
Recruiting NCT04705324 - Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion N/A
Completed NCT02012491 - Comparative Effectiveness of Pregnancy Failure Management Regimens Phase 3
Recruiting NCT05492708 - The Heartland Study
Completed NCT04017754 - Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)
Active, not recruiting NCT04156126 - Measuring Immune Tolerance to Predict Miscarriage or Failed Embryo Transfer
Completed NCT02725710 - Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration Phase 2
Recruiting NCT04182503 - Environmental Factors and Embryonic Development Project